Po S. Chung
Daejeon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Glutamate excreted by LepR⁺ BM-MSCs mitigates alcohol-associated liver disease by promoting IL-1R2⁺ monocyte migration.
Journal: Clinical and molecular hepatology
Published: April 05, 2026
Adipocyte-derived FABP4 promotes metabolism-associated steatotic liver-induced hepatocellular carcinoma by driving ITGB1-mediated β-catenin activation.
Journal: The Journal of clinical investigation
Published: April 29, 2025
Binge drinking triggers VGLUT3-mediated glutamate secretion and subsequent hepatic inflammation by activating mGluR5/NOX2 in Kupffer cells.
Journal: Nature communications
Published: November 15, 2024
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma.
Journal: Nature communications
Published: October 26, 2024
Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: September 27, 2024
CX3CR1+ macrophages interact with HSCs to promote HCC through CD8+ T-cell suppression.
Journal: Hepatology (Baltimore, Md.)
Published: March 31, 2024
Catecholamine induces Kupffer cell apoptosis via growth differentiation factor 15 in alcohol-associated liver disease.
Journal: Experimental & molecular medicine
Published: July 14, 2022
New insights in the pathogenesis of alcohol-related liver disease: The metabolic, immunologic, and neurologic pathways☆.
Journal: Liver research (Beijing, China)
Published: May 21, 2022
Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain-Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: May 28, 2019
Last Updated: 09/26/2026